MedTrace Logo

Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)

NCT04092465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2019-09-17

No results posted yet for this study

Summary

Surgery still remains the main treatment option for Non-Small Cell Lung Cancer (NSCLC) which is limited within the lung parenchyma and possibly invades the intrapulmonary or hilar nodes. The role of surgery in locally advanced NSCLC with the form of invasion of adjacent strictures or mediastinal nodes is a 30-year point of discussion and debate among thoracic surgeons, clinical and radiation oncologists, chest physicians and other related specialties. Despite the continuous debate the management of locally advanced NSCLC varies between different countries and different institutions.We try to investigate the short and long term outcomes of surgery after induction treatment performed for locally advanced NSCLC.

Conditions

  • Patient Outcome Assessment
  • Morbidity
  • Mortality

Interventions

PROCEDURE

Pulmonary parenchyma resection, lobectomy, pneumonectomy, sleeve lobectomy, extended lobectomy/pneumonectomy

Resection of the downstaged locally advanced NSCLC through formal thoracotomy

Sponsors & Collaborators

  • AHEPA University Hospital

    lead OTHER

Principal Investigators

  • CHRISTOFOROS N FOROULIS, Professor · AHEPA University Hospital

  • KYRIAKOS ANASTASIADIS, Professor · AHEPA University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2019-08-31
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04092465 on ClinicalTrials.gov